超血症相关的妄想模仿痴呆症:一个病例报告
1Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan.
Psychiatry and clinical psychopharmacology
|May 20, 2024
概括
这项研究报告了一例67岁的女性经历了手术后的认知障碍,这与氨水平升高有关. 患者的认知功能在氨量减少后得到改善,支持 Delirium 的诊断.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 氨是一种已知的神经毒素,影响能量代谢,线粒体功能和炎症.
- 这些生理功能障碍与认知和执行功能缺陷有关.
研究的目的:
- 在脊椎手术后报告和分析一种不寻常的痴呆症与认知障碍病例.
- 探索高氨血和急性认知缺陷之间的关系.
主要方法:
- 一个67岁的女性患者的病例报告.
- 在手术后对神经和肝功能进行临床观察.
- 血清氨水平和认知状态的监测.
主要成果:
- 患者患有急性肝炎,随后肝功能逐渐改善.
- 观察到急性开始的认知障碍和轻度的超氨血症.
- 认知缺陷随着血清氨水平正常化而消失.
结论:
- 患者的表现表明妄,而不是痴呆症,由于高氨血.
- 这一案例凸显了在术后认知功能障碍中考虑氨毒性的重要性.
- 需要进一步讨论痴呆症的临床诊断和病因.
更多相关视频
相关概念视频
Alzheimer's Disease: Overview
465
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
465
Dementia
111
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
111
Amnesia
121
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
121
Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180
Dissociative Amnesia
67
Dissociative amnesia is a complex psychological condition that manifests as an inability to recall personal information, often tied to traumatic or stressful events. Unlike general amnesia, individuals with this condition retain the ability to perform routine activities and procedural tasks, such as operating a phone or navigating public transportation, yet experience profound gaps in autobiographical memory. These lapses may encompass significant life events, such as suicide attempts or...
67
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120


